Strimvelis - autologous CD34+

BNF:
Not listed
Status:
Red
Decision Date:
March 2018
 

Comments

RED8: NICE HST7- Strimvelis for treating adenosine deaminase deficiency-severe combined immunodeficiency. (Decision date -March 2018) 

Red Drug Classifications

  • 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app